Your Search
- All results
- Pages
- Articles in the press
- Brochures
- Company news
- Educational resources
- News
- Podcasts
- Press releases
- Videos
- Events
User-friendly Medicines
Chapter of the book “Pharmaceutical Formulation – The Science & Technology of Dosage Forms” written by Professor Clive Wilson, Strathclyde Institute of Pharmacy & Biomedical Sciences, Glasgow and HERMES PHARMA’s Dr Martin KoeberleThe conditions of dosing may influence efficacy: for example, should the active pharmaceutical …
HERMES PHARMA Obtains Prestigious GMP Certification from Russian Authorities
The successful inspection allows HERMES PHARMA to manufacture for the Russian marketPullach, Germany, January 16, 2018 — HERMES PHARMA, the expert in user-friendly oral dosage forms, successfully completed the Good Manufacturing Practices (GMP) inspection of its production facilities by Russian authorities. The German plant in Wolfratshausen, …
HERMES PHARMA Improves Opening of Tablet Tubes Used for Lozenges, Effervescent and Chewable Tablets
New Patented Desiccant Stopper Makes Products Even More User-FriendlyPullach, Germany, Oct 18, 2016 – HERMES PHARMA, the expert in user-friendly oral dosage forms, has announced the availability of a new desiccant stopper. The patent-protected stopper features a two-step, easy-opening technique suitable for multi-dose tablet tube containers.Often, …
HERMES PHARMA Awarded European Organic Certificate
Wolfratshausen GMP Facility Meets Organic Food Trend RequirementsPullach, Germany, May 10, 2016 – HERMES PHARMA, the expert in user-friendly oral dosage forms, has announced that its facility in Wolfratshausen, Germany now also meets the requirements to produce and package organic food substances. The company has been …
HERMES PHARMA Makes Hot Melt Coating Available for the Pharma Industry
Commercial Production in GMP Environment Started to Mask the Sour and Metallic Taste of AcetylcysteinePullach, Germany, January 26, 2016 – HERMES PHARMA, the expert in user-friendly solid oral dosage forms, has announced the commercial implementation of hot melt coating (HMC) in its production facility. The implementation …
Carinthia Innovation and Research Award Conferred to HERMES PHARMA
HERMES PHARMA earned the first prize for its research in innovative oral dosage formsThe company received the Award for its research into Hot Melt Coating (HMC), a novel granulation technology. HERMES PHARMA uses HMC to mask the unpleasant bitter or sour taste inherent with many …
User-Friendly Dosage Form Expert, HERMES PHARMA, Brings Easy-to-Swallow Medicines to US Market
HERMES PHARMA has today announced plans to ramp up its expansion into the US marketPullach, Germany, August 13, 2015 – HERMES PHARMA, Europe’s largest developer and manufacturer of user-friendly solid oral dosage forms, has today announced plans to ramp up its expansion into the US market. …
Conventional Tablets May No Longer Be the Go-To-Solution
Market study reveals difficulties swallowing tablets wide-spread and opens up new revenue opportunitiesPullach, Germany, September 2, 2014 – Hermes Pharma, the expert in the development and production of user-friendly solid oral dosage forms, today announced the findings of an international survey exploring the nature of difficulties …
HERMES PHARMA Completes Successful Routine FDA Inspection of Production Facility
Inspection Opens Door for HERMES PHARMA to Increase Production of User-friendly Solid Oral Dosage Forms for the USPullach, Germany, June 26, 2013 HERMES PHARMA, a division of HERMES Arzneimittel GmbH and Europe’s largest developer and manufacturer of user-friendly solid oral dosage forms, recently completed a successful …
Swallowing Tablets is a Massive Problem for Growing Numbers of People
User-Friendly Dosage Forms Enable Pharmaceutical Companies to InnovatePullach, Germany, April 24, 2013 While the pharmaceutical industry concentrates on developing new ever more effective compounds, the basic needs of patients go often ignored. Historically, because of low cost, simplicity and public familiarity, oral application became the main …